StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > 7

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Dec 11, 2023 8:37pm

64 Views

Post# 35779076

RE:RE:RE:7

The interviewer's name is Kyle. Stagezero is not the only company he provides these phoney interviews for. Same stick, different company.
As the stock price gets closer to zero we can expect more of this mindless pumping. God save the King and us.

molotov421 wrote: I totally agree. Most of the comments seem fake. Also, pretty funny how every time Trip interviews he's so pleased with his progress....SP @ all time low and revenue down. Wake up tripster. So Frustrating...

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading